• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.人前列腺特异性膜抗原(PSMA)在人细胞和前列腺组织中的糖型。
Prostate. 2022 Jan;82(1):132-144. doi: 10.1002/pros.24254. Epub 2021 Oct 18.
2
Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma.前列腺特异性膜抗原(PSMA)在前列腺癌患者精液中的糖型。
Prostate. 2024 Apr;84(5):479-490. doi: 10.1002/pros.24666. Epub 2023 Dec 27.
3
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing.前列腺特异性膜抗原的顶端运输和折叠独立于聚糖加工过程发生。
J Biol Chem. 2006 Feb 10;281(6):3505-12. doi: 10.1074/jbc.M509460200. Epub 2005 Oct 12.
4
N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy.N-糖基化和微管完整性参与前列腺特异性膜抗原的顶端靶向:对免疫治疗的意义。
Mol Cancer Ther. 2005 May;4(5):704-14. doi: 10.1158/1535-7163.MCT-04-0171.
5
Cloning and characterization of canine prostate-specific membrane antigen.克隆和鉴定犬前列腺特异性膜抗原。
Prostate. 2013 May;73(6):642-50. doi: 10.1002/pros.22605. Epub 2013 Jan 28.
6
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
7
Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.犬前列腺癌细胞前列腺特异性膜抗原的生化特性分析。
Prostate. 2014 May;74(5):451-7. doi: 10.1002/pros.22727. Epub 2014 Jan 21.
8
Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).使用基于甲氨蝶呤的肽底物来表征前列腺特异性膜抗原(PSMA)的底物特异性。
Cancer Biol Ther. 2004 Jun;3(6):551-8. doi: 10.4161/cbt.3.6.846. Epub 2004 Jun 10.
9
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer.评估一种18F标记的氨基磷酸肽模拟物作为一种用于前列腺癌的新型前列腺特异性膜抗原靶向成像剂。
J Nucl Med. 2009 Dec;50(12):2042-8. doi: 10.2967/jnumed.109.066589. Epub 2009 Nov 12.
10
Discovery of PSMA in the prostate of the common marmoset (Callithrix jacchus).在普通狨猴(Callithrix jacchus)的前列腺中发现 PSMA。
Prostate. 2024 Aug;84(11):1086-1088. doi: 10.1002/pros.24722. Epub 2024 Apr 28.

引用本文的文献

1
In-silico structural and functional analysis of nonsynonymous single nucleotide polymorphisms in human gene.人类基因非同义单核苷酸多态性的计算机结构与功能分析
In Silico Pharmacol. 2025 Feb 25;13(1):32. doi: 10.1007/s40203-025-00319-3. eCollection 2025.
2
Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells.转移性前列腺癌细胞中前列腺特异性膜抗原的位点特异性完整N-连接糖肽表征
ACS Omega. 2022 Aug 18;7(34):29714-29727. doi: 10.1021/acsomega.2c02265. eCollection 2022 Aug 30.
3
Site-specific glycosylation of SARS-CoV-2: Big challenges in mass spectrometry analysis.SARS-CoV-2 的位点特异性糖基化:质谱分析中的重大挑战。
Proteomics. 2022 Aug;22(15-16):e2100322. doi: 10.1002/pmic.202100322. Epub 2022 Jun 22.

本文引用的文献

1
Advances in the selection of patients with prostate cancer for active surveillance.前列腺癌患者主动监测选择标准的进展
Nat Rev Urol. 2021 Apr;18(4):197-208. doi: 10.1038/s41585-021-00432-w. Epub 2021 Feb 23.
2
[Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.[吕]Lu-PSMA-617 对比卡巴他赛用于转移性去势抵抗性前列腺癌(TheraP)患者:一项随机、开放标签、2 期试验。
Lancet. 2021 Feb 27;397(10276):797-804. doi: 10.1016/S0140-6736(21)00237-3. Epub 2021 Feb 11.
3
Genomic and phenotypic heterogeneity in prostate cancer.前列腺癌的基因组和表型异质性。
Nat Rev Urol. 2021 Feb;18(2):79-92. doi: 10.1038/s41585-020-00400-w. Epub 2020 Dec 16.
4
The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.与前列腺癌进展相关的组织糖蛋白质组的复杂性和动态性。
Mol Cell Proteomics. 2021;20:100026. doi: 10.1074/mcp.RA120.002320. Epub 2021 Jan 5.
5
Global view of human protein glycosylation pathways and functions.人类蛋白糖基化途径和功能的全球视图。
Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749. doi: 10.1038/s41580-020-00294-x. Epub 2020 Oct 21.
6
Low Collision Energy Fragmentation in Structure-Specific Glycoproteomics Analysis.结构特异性糖蛋白质组学分析中的低碰撞能碎片化。
Anal Chem. 2020 Jun 16;92(12):8262-8267. doi: 10.1021/acs.analchem.0c00519. Epub 2020 Jun 4.
7
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT(proPSMA):一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
8
Imaging for Metastasis in Prostate Cancer: A Review of the Literature.前列腺癌转移的影像学检查:文献综述
Front Oncol. 2020 Jan 31;10:55. doi: 10.3389/fonc.2020.00055. eCollection 2020.
9
F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging.F-标记的、PSMA 靶向放射性示踪剂:利用放射性氟化优势进行前列腺癌分子成像。
Theranostics. 2020 Jan 1;10(1):1-16. doi: 10.7150/thno.37894. eCollection 2020.
10
Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.寻找错误地方的药物:GCPII 抑制剂在大脑外的应用。
Neurochem Res. 2020 Jun;45(6):1256-1267. doi: 10.1007/s11064-019-02909-y. Epub 2019 Nov 20.

人前列腺特异性膜抗原(PSMA)在人细胞和前列腺组织中的糖型。

Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.

机构信息

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA.

Clinical and Translational Glycoscience Research Center, Georgetown University Medical Center, Georgetown University, Washington DC, USA.

出版信息

Prostate. 2022 Jan;82(1):132-144. doi: 10.1002/pros.24254. Epub 2021 Oct 18.

DOI:10.1002/pros.24254
PMID:34662441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9646948/
Abstract

INTRODUCTION

N-glycosylation is a ubiquitous and variable posttranslational modification that regulates physiological functions of secretory and membrane-associated proteins and the dysregulation of glycosylation pathways is often associated with cancer growth and metastasis. Prostate-specific membrane antigen (PSMA) is an established biomarker for prostate cancer imaging and therapy.

METHODS

Mass spectrometry was used to analyze the distribution of the site-specific glycoforms of PSMA in insect, human embryonic kidney, and prostate cancer cells, and in prostate tissue upon immunoaffinity enrichment.

RESULTS

While recombinant PSMA expressed in insect cells was decorated mainly by paucimannose and high mannose glycans, complex, hybrid, and high mannose glycans were detected in samples from human cells and tissue. We noted an interesting spatial distribution of the glycoforms on the PSMA surface-high mannose glycans were the dominant glycoforms at the N459, N476, and N638 sequons facing the plasma membrane, while the N121, N195, and N336 sites, located at the exposed apical PSMA domain, carried primarily complex glycans. The presence of high mannose glycoforms at the former sequons likely results from the limited access of enzymes of the glycosynthetic pathway required for the synthesis of the complex structures. In line with the limited accessibility of membrane-proximal sites, no glycosylation was observed at the N51 site positioned closest to the membrane.

CONCLUSIONS

Our study presents initial descriptive analysis of the glycoforms of PSMA observed in cell lines and in prostate tissue. It will hopefully stimulate further research into PSMA glycoforms in the context of tumor staging, noninvasive detection of prostate tumors, and the impact of glycoforms on physicochemical and enzymatic characteristics of PSMA in a tissue-specific manner.

摘要

简介

N-糖基化是一种普遍存在且可变的翻译后修饰,可调节分泌蛋白和膜相关蛋白的生理功能,糖基化途径的失调常与肿瘤的生长和转移有关。前列腺特异膜抗原(PSMA)是前列腺癌成像和治疗的一种既定生物标志物。

方法

使用质谱分析法分析了昆虫细胞、人胚肾细胞和前列腺癌细胞中 PSMA 特定位点糖型的分布,以及免疫亲和富集后的前列腺组织中的分布。

结果

在昆虫细胞中表达的重组 PSMA 主要被 pauci-甘露糖和高甘露糖糖基化修饰,而在人源细胞和组织样本中检测到了复杂型、杂合型和高甘露糖型糖基化。我们注意到 PSMA 表面上糖型的分布存在有趣的空间差异——高甘露糖型糖基化是面向质膜的 N459、N476 和 N638 序列的主要糖型,而位于暴露的 PSMA 顶端结构域的 N121、N195 和 N336 位点主要携带复杂型糖基化。前几个序列中存在高甘露糖型糖基化可能是由于合成复杂结构所需的糖基化途径中的酶难以进入。与膜近端位点的有限可及性一致,位于膜最接近位置的 N51 位点未观察到糖基化。

结论

本研究首次对细胞系和前列腺组织中 PSMA 糖型进行了描述性分析。它有望进一步激发对 PSMA 糖型在肿瘤分期、前列腺肿瘤的无创检测以及糖型对 PSMA 理化和酶学特性的组织特异性影响等方面的研究。